Accueil
»
Bourse
»
Actions Paris
»

Consensus des Analystes LNA Santé

Cotation du 27/11/2020 à 17h35 LNA Santé +1,91% 47,900€

Objectif de cours au 29/11/2020

52,417 €
Potentiel de +9%
cours actuel 47,900€

Note médiane des 6 analystes

2,2
5 Vendre 4 Alléger 3 Conserver 2 Renforcer 1 Acheter

Evolution des recommandations

Recommandations 29/11/2019 29/02/2020 29/05/2020 29/08/2020 29/11/2020
Acheter 3 2 2 2 1
Renforcer 2 1 1 2 3
Conserver 1 3 3 2 2
Alléger - - - - -
Vendre - - - - -
Nb d'analystes 6 6 6 6 6
Note Médiane 1,67 2,17 2,17 2,00 2,17
Historique des objectifs 56,333€ 56,333€ 45,200€ 51,083€ 52,416€

Prévisions

2019 2020 2021
Chiffre d'affaires 527,86 552,23 648,16
EBITDA 113,90 110,02 133,36
EBIT 55,12 50,42 66,28
Résultat Net 20,83 16,22 26,72
Flux de trésorerie disponible 111,51 54,28 69,70
Dette nette 680,24 708,03 827,04
PER 22,19 28,15 17,13
Copyright ©2020, S&P Global Market Intelligence. Reproduction of CIQ Estimates in any form is prohibited except with the prior written permission of S&P Global Market Intelligence. CIQ Estimates are not investment advice and a reference to a particular investment or security, a credit rating or any observation concerning a security or investment provided in CIQ Estimates is not a recommendation to buy, sell or hold such investment or security or make any other investment decisions. S&P Global Market Intelligence, its affiliates and their third-party providers (together, “S&P Global”) do not guarantee the accuracy, adequacy, completeness or availability of any information and are not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. S&P GLOBAL DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall S&P Global be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriber’s or others’ use of CIQ Estimates.